(AVTX) Avantium Holding BV - Overview
Sector: Basic Materials | Industry: Specialty Chemicals | Exchange: AS (Netherlands) | Market Cap: 233m EUR | Total Return: 3.4% in 12m
Avg Turnover: 1.82M
Warnings
Interest Coverage Ratio -11.1 is critical
Altman Z'' -7.16 < 1.0 - financial distress zone
Extended 1w
Tailwinds
Supp Ema20, Confidence
Avantium N.V. is a Netherlands-based chemical technology company focused on the development and commercialization of bio-based plastics and chemicals. The firm operates through two primary segments: Avantium R&D Solutions and Avantium Renewable Polymers. Its core technology, YXY, catalytically converts plant-based sugars into furandicarboxylic acid (FDCA), the essential building block for polyethylene furanoate (PEF).
The companys flagship product, Releaf, utilizes PEF to provide superior barrier properties against carbon dioxide and oxygen compared to traditional petroleum-based plastics. This performance advantage extends the shelf life of packaged goods, positioning the material as a high-performance alternative in the textiles, film, and packaging industries. The bio-based chemical sector is currently driven by global decarbonization mandates and the transition toward a circular economy.
Avantium also manages a pipeline of proprietary processes, including Dawn, Parana, and Volta technologies, aimed at diversifying its renewable chemical portfolio. Examining the data at ValueRay can offer deeper insights into how these technologies impact the companys valuation. As a research-intensive business, Avantium relies on a licensing and partnership model to scale its industrial applications globally.
- Commercialization of FDCA flagship plant determines path to positive cash flow
- Strategic partnerships with global brands drive adoption of bio-based PEF packaging
- Capital expenditure requirements for scaling technology increase dilution or debt risk
- European Union plastic tax regulations incentivize shift toward renewable polymer alternatives
- High sensitivity to plant-based sugar feedstock prices impacts production margins
| Net Income: -49.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.43 > 0.02 and ΔFCF/TA 25.03 > 1.0 |
| NWC/Revenue: -220.4% < 20% (prev 5.39%; Δ -225.8% < -1%) |
| CFO/TA -0.23 > 3% & CFO -82.9m > Net Income -49.4m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 0.46 > 1.5 & < 3 |
| Outstanding Shares: last quarter (21.3m) vs 12m ago -54.66% < -2% |
| Gross Margin: -187.5% > 18% (prev -1.31%; Δ -18.6k% > 0.5%) |
| Asset Turnover: 12.19% > 50% (prev 12.47%; Δ -0.29% > 0%) |
| Interest Coverage Ratio: -11.08 > 6 (EBITDA TTM -68.2m / Interest Expense TTM 7.03m) |
| A: -0.22 (Total Current Assets 68.1m - Total Current Liabilities 146.6m) / Total Assets 356.2m |
| B: -0.80 (Retained Earnings -285.2m / Total Assets 356.2m) |
| C: -0.27 (EBIT TTM -77.9m / Avg Total Assets 292.3m) |
| D: -1.25 (Book Value of Equity -258.7m / Total Liabilities 206.6m) |
| Altman-Z'' = -7.16 = D |
| DSRI: 1.03 (Receivables 8.39m/6.52m, Revenue 35.6m/28.5m) |
| GMI: 1.00 (fallback, negative margins) |
| AQI: 0.86 (AQ_t 0.01 / AQ_t-1 0.01) |
| SGI: 1.25 (Revenue 35.6m / 28.5m) |
| TATA: 0.09 (NI -49.4m - CFO -82.9m) / TA 356.2m) |
| Beneish M = -2.81 (Cap -4..+1) = A |
As of May 24, 2026, the stock is trading at EUR 9.23 with a total of 572,510 shares traded.
Over the past week, the price has changed by +13.11%,
over one month by +24.56%,
over three months by +38.38% and
over the past year by +3.37%.
Avantium Holding BV has no consensus analysts rating.
P/S = 15.9431
P/B = 1.5006
Revenue TTM = 35.6m EUR
EBIT TTM = -77.9m EUR
EBITDA TTM = -68.2m EUR
Long Term Debt = 40.2m EUR (from longTermDebt, last quarter)
Short Term Debt = 109.1m EUR (from shortTermDebt, last quarter)
Debt = 173.6m EUR (from shortLongTermDebtTotal, last quarter) + Leases 8.53m
Net Debt = 116.1m EUR (calculated: Debt 173.6m - CCE 57.5m)
Enterprise Value = 348.8m EUR (232.7m + Debt 173.6m - CCE 57.5m)
Interest Coverage Ratio = -11.08 (Ebit TTM -77.9m / Interest Expense TTM 7.03m)
EV/FCF = -2.25x (Enterprise Value 348.8m / FCF TTM -154.8m)
FCF Yield = -44.37% (FCF TTM -154.8m / Enterprise Value 348.8m)
FCF Margin = -434.4% (FCF TTM -154.8m / Revenue TTM 35.6m)
Net Margin = -138.6% (Net Income TTM -49.4m / Revenue TTM 35.6m)
Gross Margin = -187.5% ((Revenue TTM 35.6m - Cost of Revenue TTM 102.4m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.98 (Enterprise Value 348.8m / Total Assets 356.2m)
Interest Expense / Debt = 4.05% (Interest Expense 7.03m / Debt 173.6m)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = -58.4m (EBIT -77.9m * (1 - 25.00%)) [loss with tax shield]
Current Ratio = 0.46 (Total Current Assets 68.1m / Total Current Liabilities 146.6m)
Debt / Equity = 1.14 (Debt 173.6m / totalStockholderEquity, last quarter 152.5m)
Debt / EBITDA = -1.70 (negative EBITDA) (Net Debt 116.1m / EBITDA -68.2m)
Debt / FCF = -0.75 (negative FCF - burning cash) (Net Debt 116.1m / FCF TTM -154.8m)
Total Stockholder Equity = 107.9m (last 4 quarters mean from totalStockholderEquity)
RoA = -16.89% (Net Income -49.4m / Total Assets 356.2m)
RoE = -12.56% (Net Income TTM -49.4m / Total Stockholder Equity 393.1m)
RoCE = -17.97% (EBIT -77.9m / Capital Employed (Equity 393.1m + L.T.Debt 40.2m))
RoIC = -22.36% (negative operating profit) (NOPAT -58.4m / Invested Capital 261.1m)
WACC = 7.38% (E(232.7m)/V(406.2m) * Re(10.62%) + D(173.6m)/V(406.2m) * Rd(4.05%) * (1-Tc(0.25)))
Discount Rate = 10.62% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 2.27 | Cagr: -26.30%
[DCF] Fair Price = unknown (Cash Flow -154.8m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 24.36 | Revenue CAGR: 5.72% | SUE: -2.46 | # QB: -1
EPS current Year (2026-12-31): EPS=-2.08 | Chg30d=N/A | Revisions=N/A | GrowthEPS=-22.3% | GrowthRev=+129.5%
EPS next Year (2027-12-31): EPS=-0.98 | Chg30d=N/A | Revisions=N/A | GrowthEPS=+46.4% | GrowthRev=+78.5%